Becker, Heiko 1978-
Heiko Becker researcher
VIAF ID: 3775148632938630630008 ( Personal )
Permalink: http://viaf.org/viaf/3775148632938630630008
Preferred Forms
- 100 1 _ ‡a Becker, Heiko ‡d 1978-
- 100 0 _ ‡a Heiko Becker ‡c researcher
4xx's: Alternate Name Forms (1)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2x2 phase II trial (DECIDER) | |
antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation | |
Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction | |
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small cell lung cancer | |
Einfluss von Typ-I-Interferonen auf den Phänotyp und die Funktion von follikulären T-Helferzellen | |
Epigenetics in pancreatic ductal adenocarcinoma: Impact on biology and utilization in diagnostics and treatment | |
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics | |
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model | |
Molecular genetic characterization of individual cancer cells isolated via single-cell printing | |
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia | |
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation | |
Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations | |
Pattern of recurrence and patient survival after perioperative chemotherapy with 5-fu, leucovorin, oxaliplatin and docetaxel (flot) for locally advanced esophagogastric adenocarcinoma in patients treated outside clinical trials | |
Personalized treatment selection and disease monitoring using circulating tumor DNA profiling in real-world cancer patient management | |
Progenitor like cell type of an MLL-EDC4 fusion in acute myeloid leukemia | |
Retrospektive Evaluation von Mastzellneoplasien anhand der pathologisch-anatomischen Befundberichte des Instituts für Klinische Pathologie des Universitätsklinikums Freiburg | |
Study protocol for a randomised controlled trial on pulmonary metastasectomy vs. standard of care in colorectal cancer patients with ≥ 3 lung metastases (PUCC-Trial) | |
TP53 abnormalities and chromosomal aneuploidy in acute panmyelosis with myelofibrosis | |
Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis | |
Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors | |
Water pipe smoking as a cause of secondary erythrocytosis |